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Abstract 1 
Water-filtered infrared A (wIRA) is radiation with a spectrum ranging from 780 to 1400 nm. 2 
Chlamydiaceae are obligate intracellular bacteria associated with various diseases in both animals 3 
and humans. A recent in vitro study demonstrated that wIRA combined with visible light (wIRA/VIS) 4 
has potential as a non-chemical method for the treatment of chlamydial infections without adversely 5 
affecting the cell viability. The aim of this study was to investigate the influence of various factors on 6 
the effect of wIRA/VIS on acute chlamydial infection, namely the impact of temperature, exposure 7 
intensity and infectious dose (multiplicity of infection) as well as the efficacy of the visible light 8 
component. We demonstrate that non-thermal effects contribute to the inhibition of acute chlamydial 9 
infection. Visible light enhances the inhibitory effect of wIRA on extracellular bacteria (elementary 10 
bodies or EBs). Moreover, the inhibitory effect of wIRA/VIS following treatment of EBs prior to infection 11 
correlated with increased irradiation intensity. The infectivity of mature chlamydial inclusions was 12 
significantly reduced upon wIRA/VIS exposure at all irradiation intensities investigated, suggesting the 13 
contribution of host cell factors to the anti-chlamydial effect of wIRA/VIS in the late stage of the 14 
developmental cycle. The effect of irradiation was not influenced by the infectious dose.  15 
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1. Introduction 1 
Water-filtered infrared A (wIRA) is infrared radiation with a spectrum of 780-1400 nm resulting from the 2 
light produced by a halogen bulb passing through a water cuvette to exclude wavelengths above 1400 3 
nm and through a black filter to block visible light (VIS) [1]. Various clinical trials have shown that 4 
wIRA alone and in combination with visible light (wIRA/VIS) improves acute and chronic wound 5 
healing processes [2]. Moreover, two studies showed that wIRA/VIS treatment of abdominal wounds 6 
before or after surgery not only improved wound healing and oxygen partial pressure but also 7 
significantly reduced the rate of wound infections [3-4]. Surgical site infections are most often caused 8 
by the patient’s endogenous flora. The common pathogens implicated in wound infections are the 9 
gram-positive Staphylococcus aureus and coagulase-negative staphylococci as well as the gram-10 
negative Escherichia coli and Enterococcus ssp. [5]. Another study recently demonstrated that 11 
wIRA/VIS reduced the inclusion frequency of acute chlamydial infection without adversely affecting the 12 
cell viability or inducing cytotoxicity in host cells [6]. 13 
The Chlamydiaceae are a family of gram-negative bacteria consisting of one genus designated 14 
Chlamydia (C.) [7]. These obligate intracellular pathogens have a unique developmental cycle 15 
comprising an extracellular, infectious but metabolically less active stage (elementary bodies or EBs), 16 
which transforms into replicating reticulate bodies (RBs) before differentiating back into EBs [8]. They 17 
are responsible for a wide range of diseases, some of which are considered to be a public health 18 
concern in both human and veterinary medicine. For example, some strains of C. trachomatis are the 19 
causative agent of trachoma, the leading cause of infectious preventable blindness of human beings in 20 
developing countries, whereas other strains are recognized as the most important cause of bacterial 21 
sexually transmitted disease worldwide [9]. C. pecorum, a chlamydial species well-described in 22 
veterinary medicine, is associated with various medical conditions in pigs and ruminants including 23 
abortion, keratoconjunctivitis, pneumonia, polyarthritis and meningoencephalitis [10-11]. Furthermore, 24 
C. pecorum, together with other chlamydial species normally found in animals, such as C. psittaci and 25 
C. suis, has also been identified in the eye of trachoma patients in Nepal [12]. The treatment of choice 26 
for chlamydial infection is antimicrobial therapy; however, in general, the emergence of antibiotic-27 
resistant bacteria raises concerns about the continued efficacy of this approach. Tetracycline-resistant 28 
C. suis strains, harboring the tetC resistance gene, have been isolated from asymptomatic pigs in the 29 
USA [13-14]. Horizontal transfer of this gene to various Chlamydia ssp. strains including C. 30 
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trachomatis has been demonstrated in vitro [15]. Furthermore, β-lactam antibiotics have often been 1 
reported to induce chlamydial persistence in vitro and in vivo [16]. Persistence is a reversible, viable 2 
but non-infectious chlamydial state. Though the importance of persistence in vivo is largely unknown, 3 
it might negatively impact both detection and successful antimicrobial treatment of chlamydial infection 4 
[17-18]. Taken together, new therapeutic strategies are needed to overcome current and developing 5 
problems with conventional treatment of chlamydial infections. 6 
The aim of this study was to evaluate the impact of increasing irradiation intensity on wIRA/VIS-7 
exposed chlamydial EBs and mature inclusions over a range of infectious doses, to assess the 8 
influence of visible light, and to evaluate the effect of irradiation in a temperature-controlled setting 9 
using both human (C. trachomatis serovar E and HeLa cells) and animal (C. pecorum 1710S and Vero 10 
cells) infection models. 11 
 12 
2. Materials and Methods 13 
2.1. Host cells and media 14 
Vero 76 cells (African green monkey kidney cells, CRL 1587 American Type Culture Collection 15 
(ATCC), Manassas, VA, USA) and HeLa cells (Homo sapiens cervix adenocarcinoma, CCL-2 ATCC) 16 
were cultured at 37°C with 5% CO2 in growth culture medium for cell propagation. Vero growth 17 
medium consisted of Minimal Essential Medium (MEM) with Earle’s salts, 25 mM HEPES, without L-18 
Glutamine (GIBCO, Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal calf serum (FCS, 19 
BioConcept, Allschwil, Switzerland), 4 mM GlutaMAX-I (200mM, GIBCO) and 0.2 mg/ml gentamycin 20 
(50 mg/ml, GIBCO). HeLa cell culture media were further supplemented with 1% MEM Non-Essential 21 
Amino Acids (MEM NEAA, 100x, GIBCO). Medium used for cell propagation intended for infection 22 
experiments was without gentamycin. Cells were grown on round glass coverslips (13 mm diameter, 23 
Sterilin Limited (Thermo Fisher Scientific), Cambridge, UK) in 24-well plates (Techno Plastic Products 24 
AG (TPP), Trasadingen, Switzerland) in 1 mL medium for infection experiments as previously 25 
described [6]. HeLa cells were seeded at a density of 3 x 105/well, Vero cells at a density of 2 x 26 
105/well and infection experiments were performed when cells reached at least 90% confluency. 27 
 28 
2.2. Chlamydial strains 29 
In this study, two different strains of Chlamydiaceae were used for in vitro infection experiments: 30 
Chlamydia (C.) pecorum 1710S (isolate from a swine abortion, kindly provided by Prof. J. Storz, Baton 31 
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Rouge, LA, USA) and C. trachomatis serovar E (kindly provided by Prof. R. V. Schoborg, Johnson 1 
City, TN, USA). The isolate of the C. trachomatis strain was originally obtained from S. P. Wang and 2 
C.-C. Kuo (University of Washington, Seattle, WA, USA). The isolates were both propagated in HeLa 3 
cells. In summary, isolates were suspended in infection medium and used to infect HeLa cells. After 4 
centrifugation (1000g, 60 min), infection medium was replaced by growth medium plus gentamicin (0.2 5 
mg/ml, GIBCO) and 1 ug/ml  cycloheximide (Sigma-Aldrich, Inc., St. Louis, MO, USA). After an 6 
incubation period of 46 h (C. trachomatis) or 39 h (C. pecorum), monolayers were scraped and 7 
processed using sonication and centrifugation (500g, 10 min to remove cell debris and 10,000g, 45 8 
minutes to pellet EBs). EBs were suspended in SPG medium and stored at -80 °C.  SPG medium 9 
consisted of 218 mM sucrose (Sigma-Aldrich, Inc., St. Louis, MO, USA), 3.76 mM KH2PO4 (Sigma-10 
Aldrich), 7.1 mM K2HPO4 (Merck Eurolab AG, Dietlikon, Switzerland) and 5 nm GlutaMAX-100 11 
(GIBCO). 12 
 13 
2.3. Irradiation 14 
Cultures were either exposed to water-filtered infrared A in combination with visible light (wIRA/VIS) or 15 
wIRA alone for 20 min using a wIRA radiator (hydrosun 750, Hydrosun GmbH, Müllheim, Germany). 16 
The exposure intensity of wIRA/VIS and wIRA alone, respectively, depended on the experiment. The 17 
primary radiation spectrum of wIRA/VIS encompasses 400-1400 nm with negligible doses of UVA 18 
(400-315 nm; 25-30 W/m2), UVB (315-280 nm; 15-25×10-5 W/m2) and UVC (280-100 nm; 5-21×10-5 19 
W/m2 within the range of 250-280 nm) (measurements performed by the manufacturer). wIRA 20 
irradiation was attained by the use of a black filter (RG780, Hydrosun GmbH) resulting in a spectrum 21 
of 780 up to 1400 nm. The 24-well plates were placed in a thermostat-controlled water bath (SC100, 22 
Thermo Fisher Scientific, Newington, CT, USA), which maintained a temperature of 37 °C and was 23 
used as a cooling system for the irradiated cultures as previously described [19]. Non-irradiated 24 
controls were localized on the same plate and were kept at a suitable distance from the irradiated 25 
wells in order to avoid any direct and/or indirect irradiation influence (data not shown). Additionally, the 26 
temperature was monitored using a Voltcraft thermometer (Type 2ABAc, Philips, Kassel, Germany) as 27 
previously described [6]. 28 
 29 
2.4. Study design 30 
2.4.1. Infection Experiments 31 
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The experiments were organized in two different treatment groups: i) Chlamydia-infected cells with 1 
irradiation and ii) Chlamydia-infected cells without irradiation. Non-infected and non-irradiated cells 2 
were included as negative controls (data not shown). Vero and HeLa cells were infected with either C. 3 
pecorum or C. trachomatis at a multiplicity of infection (MOI) of 1, 0.1 or 0.01 in 1 mL infection medium 4 
(growth culture medium without FCS and gentamycin). After centrifugation for 1 hour (h) at 1000 g and 5 
25 °C, infection medium was replaced by incubation medium (growth culture medium without 6 
gentamycin) containing 1 ug/ml cycloheximide (Sigma-Aldrich) and cultures were incubated at 37 °C 7 
as previously described [20]. 8 
 9 
2.4.2. Irradiation of chlamydial EBs prior to host cell infection 10 
Chlamydial EBs at a MOI 0.01, 0.1 or 1 were irradiated in 1 mL infection medium for 20 min before 11 
infection of host cells. Non-irradiated EBs were used as controls. After an incubation period of 43 h, 12 
cultures were subjected to i) immunofluorescence microscopy, or ii) infectious titer analysis, as 13 
appropriate (Figure 1A). C. pecorum EBs were used to infect Vero and HeLa monolayers. C. 14 
trachomatis EBs were applied to HeLa cells only. 15 
 16 
2.4.3. Single-dose irradiation 40 hours post infection 17 
For single-dose irradiation, HeLa and Vero monolayers were infected with C. trachomatis or C. 18 
pecorum. After an incubation period of 40 h at 37 °C, cultured cells were irradiated for 20 min. 19 
Cultures were incubated for another 3 h at 37 °C under standard culture conditions before being 20 
subjected to i) immunofluorescence microscopy, or ii) infectious titer analysis, as appropriate (Figure 21 
1B). Vero monolayers were infected with C. pecorum and HeLa cells were infected with C. trachomatis 22 
(Figure 1C). 23 
  7 
 1 
Figure 1. Study Design. (2 columns) 2 
A) Diagram of the irradiation prior to infection procedure. EBs were irradiated for 20 min and used to 3 
infect host cells. After incubating infected cell cultures for 43 h, samples were further processed and 4 
analyzed. B) Diagram of the infection and single-dose irradiation procedure. Host cells were infected, 5 
incubated for 40 h and irradiated for 20 min. After another incubation period of 3 h, samples were 6 
further processed and analyzed. C) Table shows host cells and chlamydial strains investigated within 7 
this study.  8 
 9 
2.5. Immunofluorescence microscopy 10 
Monolayers were fixed with absolute methanol (-20 °C) for 10 min and immunolabeled as described 11 
[20]. Briefly, chlamydial inclusions were detected using a Chlamydiaceae family-specific mouse 12 
monoclonal antibody directed against the chlamydial lipopolysaccharide (LPS, Clone ACI-P, 1:200; 13 
Progen, Heidelberg, Germany) and a 1:500 diluted Alexa Fluor 488-conjugated secondary goat anti-14 
mouse antibody (Molecular Probes, Eugene, OR, USA). Host and chlamydial DNA were labeled using 15 
1:1000 diluted 4’, 6-Diamidin-2’-phenylindoldihydrochlorid (DAPI, 1  µg/mL, Molecular Probes). 16 
Coverslips were mounted with FluoreGuard Mounting (Hard Set, ScyTek Laboratories Inc., Logan, UT, 17 
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USA) on glass slides and assessed using a Leica DMLB fluorescence microscope (Leica 1 
Microsystems, Wetzlar, Germany) under oil immersion at 1000-fold magnification with a 100x 2 
objective (PL FLUOTAR 100x/1.30, OIL, ∞/0.17/D, Leica Microsystems) and a 10x ocular objective 3 
(Leica L-Plan 10x/25 M, Leica Microsystems). In total, 200 cell nuclei and all chlamydial inclusions per 4 
examined field were counted as previously described [6]. Microscopic images were captured with the 5 
BonTec measuring and archiving software (BonTec, Bonn, Germany) using a UI-2250SE-C-HQ 6 
camera (uEye, IDS Imaging Development Systems GmbH, Obersulm, Germany). 7 
 8 
2.6. Chlamydial titration by sub-passage 9 
Monolayers were scraped together with supernatant at 43 hpi and stored at -80°C, followed by sub-10 
passage on the respective host cell as shown previously [6]. Fixation and immunofluorescence 11 
staining was performed as described in subsection 2.5. The number of inclusions in 30 random 12 
microscopic fields per sample was determined using a Leica fluorescence microscope at 200-fold 13 
magnification with a 20x objective (PL FLUOTAR 20x/0.50 PH2, ∞/0.17/B) and a 10x ocular objective 14 
(Leica L-Plan 10x/25 M, Leica Microsystems). The number of inclusion-forming units (IFU) in undiluted 15 
inoculum was then calculated and expressed as IFU per ml inoculum according to previously 16 
published methods [21].  17 
 18 
2.7. Statistical analysis 19 
All statistical analyses were performed with the GraphPad Quickcalcs software 20 
(www.graphpad.com/quickcalcs). If not stated differently, all results are displayed as means ± 21 
standard deviation (SD) of the indicated number of experiments. The significance of differences was 22 
estimated by t test, and a p-value of < 0.05 was considered significant. 23 
 24 
3. Results 25 
3.1. Non-thermal effects contribute to the reducing effect of wIRA/VIS exposure 26 
In a recent study, we demonstrated that thermal effects were responsible, at least in part, for the 27 
reduced chlamydial activity subsequent to wIRA/VIS irradiation [6]. Briefly, we mimicked the 28 
temperature raise induced by 20 min of wIRA/VIS at 3700 W/m2 by increasing the water bath 29 
temperature to 41 °C. Comparing these treatments by exposing Chlamydia-infected cells either to 30 
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wIRA/VIS irradiation or water bath treatment for 20 min at 40 hours post infection (hpi), we 1 
demonstrated that an increase in water bath temperature alone reduced the number of chlamydial 2 
inclusions per nucleus. In the current study, we eliminated wIRA/VIS-induced thermal effects by 3 
lowering the water bath temperature to 34 °C. The resulting intra-well temperature on top of the 4 
coverslip (at the bottom of the well) after the 20 min irradiation period (35.93±0.38 °C) was identical to 5 
non-irradiated control wells (36.10±0.1 °C) at a water bath temperature of 37 °C (Figure 2A, Figure 6 
S1A). C. trachomatis-infected HeLa cells (MOI 1) were exposed to wIRA/VIS at 3700 W/m2 for 20 min 7 
40 hpi at a water bath temperature of 34 °C and 37 °C, respectively. Non-irradiated controls were 8 
included for both conditions. Following irradiation, cultures were incubated at 37 °C for three hours 9 
before they were collected for sub-passage titer analysis. IFU/mL was calculated and expressed as 10 
percentage of their respective control. The reduction in the number of IFU/ml following irradiation in a 11 
temperature-controlled setting (water bath 34 °C, 65.99% ± 15.97%) was similar compared to 12 
irradiation at a water bath temperature of 37 °C (65.75% ± 16.29%, Figure 2B). There was no 13 
significant difference between the controls (data not shown). 14 
 15 
 16 
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Figure 2. Non-thermal effects contribute to the anti-chlamydial effect of wIRA/VIS exposure. (1 1 
column) 2 
A) 1 mL of cell culture medium was added per well and irradiated with wIRA/VIS (3700 W/m2) for 20 3 
min at a water bath temperature of 34 °C (wIRA+VIS, 34 °C) and 37 °C (wIRA+VIS, 37 °C), 4 
respectively. Non-irradiated medium was used as controls (no irradiation). Shown is the mean intra-5 
well temperature of three wells per condition after 20 min of irradiation (mean ± SD; * p < 0.05; t test). 6 
B) C. trachomatis-infected HeLa cells (MOI 1) were irradiated 40 hours post infection (hpi) with 3700 7 
W/m2 at a water bath temperature of 34 °C and 37 °C, respectively. Cultures were further incubated at 8 
37 °C, collected 43 hpi and subjected to sub-passage titer analysis. Inclusion forming units per mL 9 
(IFU/mL) are shown as percent of control (mean ± SD; * p < 0.05; n ≥ 3; t test). 10 
 11 
3.2. Visible light contributes to the increase of intra-well temperature at high exposure 12 
intensities 13 
Next, we investigated possible differences in the anti-chlamydial effect of wIRA/VIS and wIRA alone 14 
both at low and high exposure intensities. First, using a water bath set to 37 °C, we measured the 15 
intra-well temperature during an irradiation period of 20 min by exposing cell culture medium to 16 
wIRA/VIS (wIRA+VIS 1000, wIRA+VIS 3700) at the applied dose of 1000 W/m2 (Figure 3A) and 3700 17 
W/m2 (Figure 3B), respectively. The corresponding exposure intensity of wIRA alone (wIRA 650, wIRA 18 
2000) was 650 and 2000 W/m2, respectively. There was no difference in intra-well temperature 19 
between wIRA/VIS (36.73 °C ± 0.06 °C) and wIRA alone (36.73 °C ± 0.12 °C) at a low irradiation dose 20 
after 20 min of irradiation. Furthermore, the resulting intra-well temperature for both conditions did not 21 
exceed 37 °C, but the difference compared to the control (36.27 °C ± 0.06 °C) was significant. 22 
However, at high exposure intensities, intra-well temperature following wIRA/VIS treatment (39.17 °C 23 
± 0.15 °C) was significantly increased compared to irradiation with wIRA alone (38.03 °C ± 0.15 °C).  24 
 25 
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 1 
Figure 3. Visible light contributes to the increase of intra-well temperature at high exposure 2 
intensities. (1.5 columns) 3 
1 mL of cell culture medium was added per well and irradiated with wIRA/VIS (wIRA+VIS) or wIRA 4 
alone (wIRA) for 20 min at A) 1000 and B) 3700 W/m2, respectively. The corresponding exposure 5 
intensity of wIRA alone was A) 650 and B) 2000 W/m2 (wIRA 650, 2000), respectively. The water bath 6 
temperature was 37 °C. Non-irradiated medium was used as control. Shown is the mean intra-well 7 
temperature of three wells per condition after 20 min of irradiation (mean ± SD; * n=3, p < 0.05; t test). 8 
 9 
3.3. The reduction in infectivity of mature chlamydial inclusions by wIRA alone is independent 10 
of the addition of visible light 11 
To determine the possible contribution of visible light to the effect of wIRA/VIS irradiation on mature 12 
chlamydial inclusions, we used both human (C. trachomatis-infected HeLa cells) and animal (C. 13 
pecorum-infected Vero cells) cell culture models as previously described [6]. Cells were infected with 14 
MOI 0.1 and incubated for 40 hours prior to irradiation for 20 min with either wIRA/VIS or wIRA alone 15 
at a water bath temperature of 37 °C. The exposure intensity of wIRA/VIS was 1000 W/m2 (wIRA+VIS 16 
1000) at low and 3700 W/m2 (wIRA+VIS 3700) at high irradiation doses. The corresponding exposure 17 
intensities with wIRA alone were 650 W/m2 (wIRA 650) and 2000 W/cm2 (wIRA 2000), respectively. 18 
Non-irradiated, infected HeLa or Vero cultures were used as controls. After a further incubation period 19 
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of three hours, cultures were collected for sub-passage titer analysis. Following wIRA/VIS irradiation at 1 
low exposure intensity, the IFU/mL was reduced compared to the control for both C. trachomatis in 2 
HeLa (66.53% ± 17.18%, Figure 4A) and for C. pecorum in Vero cells (50.40% ± 18.06%). However, 3 
only for C. pecorum in Vero cells was IFU/ml significantly reduced by irradiation with wIRA alone 4 
(63.98% ± 6.18%, Figure 4C). In contrast, there was no significant difference between the reduction 5 
caused by wIRA/VIS treatment and wIRA alone, regardless of the cell culture model, at high irradiation 6 
doses. For C. pecorum, IFU/mL was 26.34% ± 10.71% for wIRA/VIS and 50.58% ± 13.81% for wIRA 7 
alone compared to the control (Figure 4B), whereas for C. trachomatis, IFU/ml was 48.49% ± 14.14% 8 
and 63.72% ± 17.82%, respectively (Figure 4D). Similar results were obtained for C. trachomatis at 9 
MOI 1 (Figure S2A-B) and MOI 0.01 (Figure S2C-D). 10 
 11 
 12 
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Figure 4. The reduction in infectivity of mature chlamydial inclusions by wIRA alone is 1 
independent of the addition of visible light. (2 columns) 2 
HeLa cells infected with C. trachomatis (MOI 0.1) were irradiated or not with A) wIRA/VIS (wIRA+VIS 3 
1000) or wIRA alone (wIRA 650), and B) wIRA+VIS 3700 or wIRA alone (wIRA 2000) at 40 hours post 4 
infection (hpi) for 20 min (water bath temperature 37 °C), respectively. Non-irradiated cultures were 5 
used as controls. Cultures were incubated for another three hours and then collected for sub-passage 6 
titer analysis. Inclusion forming units per mL (IFU/mL) are shown as percent of control (mean ± SD; * 7 
p < 0.05; n ≥ 3; t test). 8 
Vero cells were infected with C. pecorum at MOI 0.1 and irradiated or not at 40 hours post infection 9 
(hpi) for 20 min (water bath temperature 37 °C) with C) wIRA+VIS 1000 (1000 W/m2) or wIRA alone 10 
(wIRA 650) and D) wIRA+VIS 3700 (3700 W/m2) or wIRA alone (wIRA 2000), respectively. Non-11 
irradiated cultures were used as controls. Cultures were incubated for another three hours and then 12 
collected for sub-passage titer analysis. Inclusion forming units per mL (IFU/mL) are shown as percent 13 
of control (mean ± SD; * p < 0.05; n ≥ 3; t test). 14 
 15 
3.4. The inhibitory effect of wIRA/VIS on the infectivity of EBs is influenced by visible light 16 
In a previous publication, we reported that irradiation of EBs of two different chlamydial strains with 17 
wIRA/VIS at 3700 W/m2 for twenty minutes prior to infection of their respective host cells dramatically 18 
reduced the infectivity of EBs [6]. In the current study, it was our goal to determine the effect of visible 19 
light on extracellular EBs at both low (1000 W/m2) and high (3700 W/m2) irradiation doses using 20 
irradiated C. trachomatis and C. pecorum EBs to subsequently infect HeLa cells or HeLa and Vero 21 
cells, respectively. After 43 h of incubation, cultures were either fixed in methanol, immunolabeled and 22 
analyzed or collected for subsequent titration by sub-passage as described in the Materials and 23 
Methods section (“2.6. Chlamydial titration by sub-passage”). The infectivity rate of each condition 43 24 
hpi was evaluated (data not shown). Representative microscopic pictures were taken at 1000-fold 25 
magnification (Figure 5). While the infectivity of EBs was reduced for both C. pecorum in Vero 26 
(70.88% ± 16.26%, Figure 6A) and C. trachomatis in HeLa cells (72.83% ± 8.61%, Figure 6C) 27 
following wIRA/VIS treatment of extracellular EBs at a low exposure intensity, wIRA alone only 28 
significantly reduced the IFU/mL of C. pecorum in Vero cells (82.83% ± 5.97%, Figure 6A). As 29 
opposed to this, the infectivity of EBs was reduced for both C. pecorum in Vero and C. trachomatis in 30 
HeLa cells using wIRA alone at high irradiation doses. However, there was a marked difference 31 
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between wIRA/VIS and wIRA without visible light for both cell culture models. Sub-passage titer 1 
analysis confirmed that IFU/mL was reduced more efficiently by wIRA/VIS treatment of C. pecorum 2 
EBs before infecting Vero cells (23.17% ± 6.37%) compared to wIRA alone (67.41% ± 12.92%, Figure 3 
6B). Irradiation of C. trachomatis EBs prior to infection of HeLa cells provided similar results with 4 
10.85% ± 5.42% for wIRA/VIS and 79.81% ± 7.27% for wIRA without visible light, respectively (Figure 5 
6D). For C. pecorum in HeLa cells, the infectivity of EBs was reduced following wIRA/VIS treatment at 6 
both low (67.23% ± 9.82%) and high (33.77% ± 4.82%) irradiation doses, but not if EBs were 7 
irradiated with wIRA alone (Figure S3). 8 
 9 
 10 
Figure 5. Immunofluorescence Microscopy Images. (1.5 columns) 11 
  15 
Chlamydial EBs (C. pecorum, C. trachomatis) at MOI 0.1 were exposed to wIRA/VIS (wIRA+VIS 3700, 1 
exposure intensity: 3700 W/m2) or wIRA alone (wIRA 2000) prior to infection of HeLa and Vero cells. 2 
Cultures were fixed 43 hours post infection (hpi) and immunolabeled with anti-chlamydial LPS (green) 3 
and DAPI (blue). Representative microscopic pictures at 1000x magnification are shown. White scale 4 
bars = 10 µm. 5 
 6 
 7 
Figure 6. The inhibitory effect of wIRA/VIS on the infectivity of EBs is influenced by visible 8 
light. (2 columns) 9 
A) EBs of C. pecorum were irradiated with wIRA/VIS (wIRA+VIS 1000, 1000 W/m2) or wIRA alone 10 
(wIRA 650, 650 mW/cm2) and B) wIRA+VIS 3700 (3700 mW/cm2) or wIRA alone (wIRA 2000, 2000 11 
mW/cm2), respectively, prior to infection of Vero cells at a MOI of 0.1 (water bath 37 °C). Cultures 12 
  16 
were incubated for 43 hours and collected for sub-passage titer analysis. Non-irradiated EBs were 1 
used as controls. Inclusion forming units per mL (IFU/mL) are shown as percent of control (mean ± 2 
SD; * p = 0.05; n = 3; t test). C) C. trachomatis EBs were irradiated with wIRA/VIS (wIRA+VIS 1000) or 3 
wIRA alone (wIRA 650) and D) wIRA+VIS 3700 or wIRA 2000, respectively, prior to infection of HeLa 4 
cells at a MOI of 0.1 (water bath 37 °C). The numbers of inclusion forming units per mL (IFU/mL) are 5 
represented as percent of control (mean ± SD; * p = 0.05; n = 3; t test). 6 
 7 
3.5. The inhibitory effect of wIRA/VIS on the infectivity of EBs depends on irradiation intensity 8 
but is independent of the chlamydial infectious dose 9 
To further evaluate the influence of the chlamydial infectious dose and wIRA/VIS intensity on the anti-10 
chlamydial effect of irradiation, C. trachomatis EBs at MOI 0.01, 0.1 and 1 were irradiated with 11 
wIRA/VIS at low (1000 W/m2, wIRA+VIS 1000), intermediate (2000 W/m2, wIRA+VIS 2000) and high 12 
(3700 W/m2, wIRA+VIS 3700) exposure intensities for 20 min at a water bath temperature of 37 °C 13 
prior to infection of HeLa cells. After 43 hours of incubation, cultures were collected and subjected to 14 
titration by sub-passage. IFU/mL was calculated and expressed as percentage of the control. 15 
Regardless of the MOI, wIRA/VIS reduced the infectivity of EBs in a dose-dependent manner. At MOI 16 
1, the IFU/mL for wIRA+VIS 3700, wIRA+VIS 2000 and wIRA+VIS 1000 was 30.75% ± 11.89%, 17 
61.16% ± 15.78% and 81.87% ± 12.70%, respectively (Figure 7A), whereas at MOI 0.1, it was 10.85% 18 
± 5.42%, 45.21% ± 8.08% and 72.83 ± 8.61%, respectively (Figure 7B). Finally, MOI 0.01 yielded 19 
13.30% ± 3.26% subsequent to treatment with wIRA+VIS 3700, 36.46% ± 2.94% with wIRA+VIS 2000 20 
and 90.25% ± 35.81% with wIRA+VIS 1000, respectively (Figure 7C). At low irradiation doses, the 21 
reduced infectivity was significant only at MOI 0.1. Prior to the infection experiments, temperature 22 
profiles as shown in Figures 2A, 3 and S1A were established, indicating that, at all irradiation 23 
intensities evaluated, the addition of VIS to wIRA irradiation did not affect the temperature measured 24 
in the wells (Figure S1B). 25 
 26 
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 1 
Figure 7. The inhibitory effect of wIRA/VIS on the infectivity of EBs depends on the irradiation 2 
intensity but is independent of the infectious dose. (1 column) 3 
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C. trachomatis EBs were exposed to wIRA/VIS at various irradiation intensities (1000, 2000, 3700 1 
W/m2) prior to infection of HeLa cells at a A) MOI of 1, B) MOI of 0.1 and C) MOI of 0.01 (water bath 2 
37 °C). Non-irradiated EBs were used as controls. After 43 hours of incubation, cultures were 3 
collected and subjected to sub-passage titer analysis. Inclusion forming units per mL (IFU/mL) are 4 
presented as percent of control (mean ± SD; * p < 0.05; n = 3; t test).  5 
 6 
3.6. The reduction in infectivity of mature chlamydial inclusions caused by wIRA/VIS is 7 
independent of both irradiation intensity and chlamydial infectious dose 8 
To complete our evaluation of the influence of wIRA/VIS at different exposure intensities on Chlamydia 9 
at various MOI, we used the same setup as described in subsection 3.5, but, instead of irradiating EBs 10 
prior infection, we irradiated C. trachomatis-infected HeLa cells 40 hpi. Cultures were collected and 11 
further processed for sub-passage titer analysis three hours after wIRA/VIS treatment (43 hpi). Again, 12 
the result was not influenced by the MOI. Additionally, we observed that wIRA/VIS similarly reduced 13 
IFU/ml after treatment of mature chlamydial inclusions, regardless of the irradiation intensity. At MOI 1, 14 
IFU/mL as percent of the control was 66.58% ± 7.08% for wIRA+VIS 3700, 75.46% ± 11.42% for 15 
wIRA+VIS 2000 and 63.69% ± 6.54% for wIRA+VIS 1000 (Figure 8A). Almost identical results were 16 
found at MOI 0.1 with 48.49% ± 14.14%, 56.59% ± 26.54% and 66.53% ± 17.18% Figure 8B, and at 17 
MOI 0.01 with 43.48% ± 20.52%, 62.97% ± 17.95% and 65.23% ± 20.57% for wIRA+VIS 3700, 18 
wIRA+VIS 2000 and wIRA+VIS 1000, respectively (Figure 8C). 19 
 20 
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 1 
Figure 8. The reduction in infectivity of mature chlamydial inclusions caused by wIRA/VIS is 2 
independent of both irradiation intensity and infectious dose. (1 column) 3 
HeLa cells infected with C. trachomatis at an A) MOI of 1, B) MOI of 0.1, and C) MOI of 0.01 were 4 
irradiated or not with wIRA/VIS at various intensities (1000, 2000, 3700 W/m2) 40 hours post infection 5 
(water bath temperature 37 °C) and incubated for another three hours. Cultures were then collected 6 
  20 
and sub-passage titer analysis was performed. The numbers of inclusion forming units per mL 1 
(IFU/mL) are shown as percent of control (mean ± SD; * p < 0.05; n ≥ 3; t test). 2 
 3 
4. Discussion 4 
Blinding trachoma afflicts over 300 million people globally, most of whom live in developing countries 5 
[22]. Recommended treatment for trachoma includes either a single dose of azithromycin or topical 6 
application of tetracycline twice daily for six weeks [16, 22-24]. However, the recent detection of 7 
tetracycline-resistant C. suis strains in the USA and Europe stresses the importance of developing 8 
alternative treatment for chlamydial infection [13, 25-27]. This issue becomes even more urgent if we 9 
consider that mixed infections with C. trachomatis and C. suis were found in the eyes of trachoma 10 
patients in Nepal [12] and that horizontal transfer of the tetC resistance gene from the C. suis R19 11 
strain to C. trachomatis was shown in vitro [15, 28]. 12 
In a recent publication, the first to our knowledge, to evaluate the effects of wIRA/VIS on Chlamydia in 13 
vitro, we demonstrated that water-filtered infrared A in combination with visible light (wIRA/VIS) has 14 
potential as an easily applied, non-chemical technique to inhibit acute chlamydial infection in vitro 15 
without inducing cytotoxicity in host cells. For example, we showed that wIRA/VIS did not activate the 16 
extracellular signal-regulated kinase 1/2 (ERK 1/2) [6]. ERK 1/2, in turn, directly regulates Matrix 17 
Metalloproteinase (MMP)-1, an enzyme involved in the process of premature skin aging and which is 18 
expressed in response to the potentially carcinogenic ultraviolet light (UV)B and UVA but also infrared 19 
A radiation [29-34]. Moreover, the MMPs serve as pro-fibrotic endopeptidases and are important 20 
factors in the scarring process of trachoma [35]. Furthermore, using the resorufin-based AlamarBlue 21 
assay, we showed that the viability of HeLa cells is not impaired after wIRA/VIS treatment for 4h at the 22 
highest possible dose of 3700 W/m2 [6]. Also in the previous report, in order to gain first insights into 23 
the mechanism of action of the wIRA/VIS anti-chlamydial effect, instead of irradiating the cells with 24 
wIRA/VIS 40 hpi, we increased the water bath temperature thereby mimicking the irradiation-induced 25 
temperature rise within the wells from approximately 36 °C up to 39 °C. The reduction in the number of 26 
mature chlamydial inclusions (percent infection) compared to the control 43 hpi was similar to that 27 
caused by wIRA/VIS treatment. These findings led us to the hypothesis that the inhibiting effect of 28 
wIRA/VIS is likely caused, at least in part, by a thermal-induced mode of action [6].  29 
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In the current study, we continue to investigate the mechanism(s) of action of the wIRA/VIS anti-1 
chlamydial effect. We demonstrate that the infectivity of mature chlamydial inclusions is also inhbited 2 
when the irradiation-induced increase of intra-well temperature is prevented by using a temperature-3 
controlled setting for wIRA/VIS exposure. We show here that both thermal and non-thermal effects 4 
play a role in the anti-chlamydial mechanism of wIRA/VIS.  5 
However, these components of irradiation are not significantly additive, which is in accordance with 6 
published experiments regarding solar disinfection (SODIS). SODIS is a non-chemical water treatment 7 
system used in developing countries, whereby light and thermal energy of the sun is used to purify 8 
microbially contaminated drinking water. A synergistic effect of light energy, mainly produced by UVB 9 
(280-320 nm) as well as UVA (320-400 nm), and thermal energy, induced by infrared irradiation, was 10 
only observed for water temperatures exceeding 45 °C [36-38].  11 
Our results herein show that visible light enhances the inhibitory effect of wIRA on extracellular EBs at 12 
all exposure intensities investigated. Moreover, the infectivity of extracellular EBs was also 13 
significantly reduced by wIRA irradiation alone at high irradiation doses. These findings are supported 14 
by empiric data showing that chlamydiae have a remarkably high environmental survival rate, 15 
especially in cool, dry and dark conditions [39]. For example, EBs of C. abortus, the causing agent of 16 
enzootic ovine abortion, remain infectious in the environment for at least several days, and cold 17 
outdoor temperatures close to or below freezing may prolong their viability for weeks or even months 18 
[40-41]. These observations suggest that light and elevated temperatures reduce the viability and 19 
infectivity of extracelluar EBs, which corresponds to the results of our in vitro experiments. 20 
In contrast to irradiation of EBs alone, we show here that the infectivity of mature chlamydial inclusions 21 
is equally reduced in both the presence and absence of visible light, indicating that visible light does 22 
not contribute to the anti-chlamydial effect on mature chlamydial inclusions. This suggests that the 23 
host cell itself, in response to wIRA/VIS exposure, plays a role in exerting the wIRA/VIS-dependent 24 
inhibitory effect on intracellular chlamydiae, possibly by eliciting a pro-inflammatory response.  25 
This hypothesis is supported by other observations made in this study and our previous study. First, 26 
the anti-chlamydial efficacy of irradiation differed if the same treatment parameters were applied at the 27 
very beginning of the developmental cycle (extracellular EBs) or at a late stage of infection (40 hpi). 28 
Second, wIRA/VIS treatment at 40 hpi similarly reduced the number of RBs and EBs within an 29 
inclusion at 40 hpi [6], thus indicating that intracellular EBs and RBs are equally vulnerable to 30 
wIRA/VIS after a single dose of irradiation. Third, we detected an up-regulation of pro-inflammatory 31 
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cytokines (MIF/GIF, Serpin E1, RANTES, IL-6, IL-8) and chemokines (IL-16, IP-10, ENA-78, MIG, 1 
MIP-1α/β) at 43 hpi subsequent to wIRA/VIS exposure, which was identical to what we detected after 2 
either chlamydial infection alone or infection combined with wIRA/VIS treatment [6]. It is also possible 3 
that intrainclusional Chlamydia are protected from the extracellular environment (including visible light) 4 
similar to Legionella pneumophila within amoebae [42].  5 
Unfortunately, the exact mechanism of the interaction between cellular structures and wIRA irradiation 6 
is still not entirely understood. While the formation of reactive oxgen specimen (ROS) and 7 
mitochondrial superoxide formation as well as changes in the mitochondrial membrane potential have 8 
been reported in connection with a wIRA irradiation dose of 1050 W/m2 and unknown thermal 9 
fluctation [43], Höhn et al. [44] found neither evidence for any of these cellular reactions nor for 10 
increase of Ca2+ release and protein as well as DNA oxidation while irradiating human dermal 11 
fibroblasts at an exposure intensity of 1780 W/m2 in a temperature-controlled setting. As we were able 12 
to create a similar setup involving thermally controlled irradiation, it seems unlikely but not impossible 13 
that any of these responses are solely responsible for the inhibitory effect of wIRA on mature 14 
chlamydial inclusions. Given the indication that pro-inflammatory cytokines and chemokines are 15 
released in the context of wIRA/VIS irradiation on cells alone, and that VIS does not influence mature 16 
chlamydial inclusions, it is possible that wIRA overstrains the wide and complex range of anti-17 
apoptotic and immunregulating mechanisms offered by Chlamydia [45]. Further studies are needed to 18 
prove or disprove this hypothesis. 19 
In addition, while we demonstrate that visible light does not significantly contribute to the anti-20 
chlamydial effect of wIRA/VIS on mature chlamydial inclusions, Wasson et al. [46] has shown an 21 
inhibitory effect on chlamydial growth following treatment of infected cells with violet light alone at a 22 
wavelength of 405 nm for 88 seconds at 2 and 24 hpi, respectively. Irradiation at early stages of 23 
chlamydial infection may undergo a mode of action similar to extracellular EBs and early inclusions 24 
might be more vulnerable to visible light, whereas its effect on inclusions in the late stage of 25 
chlamydial infection is less pronounced. Also, in the current study, the measured IFU/ml following 26 
irradiation of mature inclusions at 40 hpi was equally decreased by wIRA/VIS treatment at all exposure 27 
intensities evaluated, while the reduction of EB infectivity following extracellular EB irradiation was 28 
irradiation intensity-dependent. Again, these data indicate marked differences for the vulnerability of 29 
Chlamydia to wIRA/VIS in the late, intracellular stage compared to the extracellular stage of the 30 
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developmental cycle, suggesting a complex yet unknown interaction between irradiation, chlamydiae 1 
and the host cell.  2 
The effect of wIRA/VIS on extracelluar EBs is in accordance to the Bunsen-Roscoe reciprocity law for 3 
ultraviolet (UV) irradiation, which states that “microbial inactivation is dependent on dose and dose is 4 
the product of UV intensity expressed in mW per cm2 and exposure time expressed in seconds” [47]. 5 
The effect of treatment duration was not investigated because the exposure time was kept at a 6 
constant 20 min and therefore had no impact on our results.  7 
Finally, we wanted to investigate the influence of the infectious dose (MOI) on wIRA/VIS-induced 8 
reduction of chlamydial infectivity. We found that the MOI did not affect the relative efficacy of 9 
irradiation.  10 
In summary, we, for the first time, show that yet unknown non-thermal effects contribute to the 11 
decrease in the infectivity of Chlamydia caused by wIRA/VIS irradiation. Additionally, using both 12 
animal and human in vitro models, we show evidence that the host cell significantly influences the 13 
effect of irradiation on intracellular chlamydiae. For example, while wIRA/VIS irradiation of extracelluar 14 
EB reduces the subsequent infectivity of these EBs in an irradiation intensity-dependent manner, the 15 
detrimental effect on the infectivity of mature chlamydial inclusions occurrs equivalently at all 16 
irradiation intensities evaluated. Furthermore, we show that extracellular EBs are highly sensitive to 17 
visible light (VIS); whereas, in contrast, we report no significant difference between the reduced 18 
infectivity of wIRA/VIS-irradiated or wIRA-irradiated mature chlamydial inclusions. These findings 19 
might facilitate the future use of wIRA/VIS as an alternative therapeutic strategy or as a safe and non-20 
harmful method for surface decontamination. 21 
 22 
23 
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Supporting Information 1 
 2 
Figure S1.  3 
Additional temperature profiles. 4 
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 1 
Figure S2.  2 
The effect of wIRA/VIS and wIRA alone on mature C. trachomatis inclusions at MOI 1 (Fig. S2A, B) 3 
and MOI 0.01 (Figure S2C, D). 4 
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 1 
Figure S3. 2 
The effect of wIRA/VIS and wIRA alone on C. pecorum EBs at MOI 0.1 prior to infection of HeLa cells 3 
at A) low (1000 W/m2) and B) high (3700 W/m2) exposure intensities. 4 
